These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8030717)

  • 1. Angina and myocardial infarction with use of leuprolide acetate.
    McCoy MJ
    Am J Obstet Gynecol; 1994 Jul; 171(1):275-6. PubMed ID: 8030717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angina pectoris and myocardial infarction with the use of leuprolide acetate.
    Pierce EJ
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1323. PubMed ID: 7726282
    [No Abstract]   [Full Text] [Related]  

  • 3. Massive ascites after leuprolide acetate administration for the treatment of leiomyomata uteri.
    Lee MJ; Kazer RR
    Fertil Steril; 1992 Aug; 58(2):416-8. PubMed ID: 1633912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukopenia induced by leuprolide acetate depot.
    Grau E; Torrecilla T; Real E; Sempere J
    Ann Pharmacother; 1994 Feb; 28(2):283-4. PubMed ID: 8173155
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advanced endometriosis treatment with leuprolide acetate].
    Valdés P; Sierralta P
    Rev Chil Obstet Ginecol; 1993; 58(5):405-10. PubMed ID: 7991863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas.
    Palomba S; Orio F; Falbo A; Oppedisano R; Tolino A; Zullo F
    Fertil Steril; 2008 Jul; 90(1):165-73. PubMed ID: 18001721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry of vascular changes in leuprolide acetate-treated leiomyomas.
    Mesia AF; Gahr D; Wild M; Mittal K; Demopoulos RI
    Am J Obstet Gynecol; 1997 May; 176(5):1026-9. PubMed ID: 9166163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years.
    Friedman AJ; Daly M; Juneau-Norcross M; Gleason R; Rein MS; LeBoff M
    Hum Reprod; 1994 Sep; 9(9):1618-25. PubMed ID: 7836510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulipristal acetate versus leuprolide acetate for uterine fibroids.
    Donnez J; Tomaszewski J; Vázquez F; Bouchard P; Lemieszczuk B; Baró F; Nouri K; Selvaggi L; Sodowski K; Bestel E; Terrill P; Osterloh I; Loumaye E;
    N Engl J Med; 2012 Feb; 366(5):421-32. PubMed ID: 22296076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short-term therapy of uterine fibromyomatosis with GN-Rh analog].
    Massacesi M; Milkowski M; Gianfranceschi C; Massacesi L
    Minerva Ginecol; 1992 Dec; 44(12):641-4. PubMed ID: 1491772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leuprolide acetate depot for the treatment of uterine leiomyomas. Changes in bone density, uterine volume and uterine vascular resistive index.
    Rivlin ME; Patel RB; Hess LW; Hess DB; Meeks GR
    J Reprod Med; 1994 Sep; 39(9):663-6. PubMed ID: 7807474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation of lupus nephritis in association with leuprorelin injection for uterine leiomyoma.
    Metcalfe W; Boulton-Jones JM
    Nephrol Dial Transplant; 1997 Aug; 12(8):1699-700. PubMed ID: 9269652
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial.
    Palomba S; Russo T; Orio F; Tauchmanovà L; Zupi E; Panici PL; Nappi C; Colao A; Lombardi G; Zullo F
    Hum Reprod; 2002 Dec; 17(12):3213-9. PubMed ID: 12456626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
    Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD
    Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Size reduction of uterine myomas with monthly administered leuprolide acetate].
    Cheviakoff S; Bocaz JA; Martínez L; Romero C
    Rev Chil Obstet Ginecol; 1994; 59(6):416-20; discussion 420-1. PubMed ID: 7569160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aborted leiomyosarcoma after treatment with leuprolide acetate.
    Mesia AF; Williams FS; Yan Z; Mittal K
    Obstet Gynecol; 1998 Oct; 92(4 Pt 2):664-6. PubMed ID: 9764655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Submucous myomas treated with gonadotropin releasing hormone agonist and resulting in vaginal hemorrhage. A case report.
    Thorp JM; Katz VL
    J Reprod Med; 1991 Aug; 36(8):625-6. PubMed ID: 1941808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [GnRH analogues in the management of uterine leiomyoma].
    Matsuo H; Maruo T
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():75-9. PubMed ID: 16689288
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group].
    Stolz W; Pfützenreuter N
    Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.